AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
222.34
+3.63 (1.66%)
Nov 11, 2025, 11:38 AM EST - Market open
AbbVie Revenue
AbbVie had revenue of $15.78B in the quarter ending September 30, 2025, with 9.10% growth. This brings the company's revenue in the last twelve months to $59.64B, up 7.40% year-over-year. In the year 2024, AbbVie had annual revenue of $56.33B with 3.71% growth.
Revenue (ttm)
$59.64B
Revenue Growth
+7.40%
P/S Ratio
6.49
Revenue / Employee
$1,084,436
Employees
55,000
Market Cap
392.95B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 56.33B | 2.02B | 3.71% |
| Dec 31, 2023 | 54.32B | -3.74B | -6.44% |
| Dec 31, 2022 | 58.05B | 1.86B | 3.30% |
| Dec 31, 2021 | 56.20B | 10.39B | 22.69% |
| Dec 31, 2020 | 45.80B | 12.54B | 37.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
| Abbott Laboratories | 43.84B |
ABBV News
- 3 days ago - Healthcare Q3 Dividend Roundup: I Prefer AbbVie Over Pfizer - Seeking Alpha
- 8 days ago - Biotech is back. Here's why these rallying stocks belong in your portfolio now. - Market Watch
- 9 days ago - ADP, Snap-on Lead 14 Companies To Announce Annual Increases In First Half Of November - Seeking Alpha
- 10 days ago - Best Dividend Aristocrats For November 2025 - Seeking Alpha
- 10 days ago - AbbVie Inc. (ABBV) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - AbbVie Raises 2025 Outlook Helped By Strong Immunology Growth, Boost Dividend - Benzinga
- 11 days ago - AbbVie: Why Q3 Confirms Its Immunology Dominance - Seeking Alpha
- 11 days ago - AbbVie Lifts Profit Outlook as Sales Rise - WSJ